Isolated adrenocorticotropic hormone deficiency following immune checkpoint inhibitors treatment often occurs in polyglandular endocrinopathies

BACKGROUND: With the increasing application of immune checkpoint inhibitors (ICI) in cancer therapy, the occurrence of isolated adrenocorticotropic hormone deficiency (IAD), as an adverse effect, is also on the rise. Nevertheless, there are only a few studies regarding IAD induced by ICI. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hong, Zhang, Lei, Zhao, Lin, Li, Xiaomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324167/
https://www.ncbi.nlm.nih.gov/pubmed/37415148
http://dx.doi.org/10.1186/s12902-023-01397-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324167/
https://www.ncbi.nlm.nih.gov/pubmed/37415148
http://dx.doi.org/10.1186/s12902-023-01397-0

Ejemplares similares